Zepbound is a newly approved weight-loss drug that contains the active ingredient tirzepatide, a GIP and GLP-1 receptor agonist. It is used for weight loss in adults with obesity. The drug works by decreasing appetite and slowing the movement of food from the stomach, making the individual feel full more quickly and for a longer period of time. Zepbound is a once-weekly injection given under the skin. It is expected to be available at a list price of $1,059.87 for a month's supply, but the actual cost may vary depending on insurance coverage and the pharmacy used
. The drug is also known as Mounjaro, which is marketed under a different brand name for a different use, specifically for diabetes control
. The main ingredient, tirzepatide, mimics two hormones naturally found in the body
. The safety data sheet for Zepbound is available, and it is not regulated as dangerous goods
. The drug may have potential positive effects on weight loss, but the cost and long-term use are highlighted as potential challenges
